Tag: Junshi Biosciences

Biotechnology

Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details

Distribution of Etesevimab/JS016 in the US Reopened | BioSpace

Added to Collection on: 2021-08-29 12:00:00

Tags for this article:

Biotechnology

Coronavirus spike protein

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Announces 2021 Interim Financial Results - GlobeNewswire

Added to Collection on: 2021-08-30 23:26:15

Tags for this article:

Drugs

Health care

Life Sciences

Antiviral drugs

Biotechnology

Immunology

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab ...

Added to Collection on: 2021-09-19 11:26:15

Tags for this article:

Coronavirus spike protein

COVID-19

Emergency use authorization

Shanghai

China

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Announces Full Year 2021 Financial Results and Provides Corporate Updates

Added to Collection on: 2022-03-31 19:36:17

Tags for this article:

Antiviral drugs

Emergency use authorization

COVID-19

Junshi

Severe acute respiratory syndrome

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with ...

Added to Collection on: 2022-09-20 18:16:13

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with

Added to Collection on: 2022-09-20 15:23:36

Tags for this article:

Non-small-cell lung carcinoma

Treatment of lung cancer

Pemetrexed

Progression-free survival

Shanghai Junshi Biosciences

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Announces Submission of a Marketing Authorization Application to the ...

Added to Collection on: 2022-11-16 04:13:54

Tags for this article:

RTT

Clinical medicine

Non-small-cell lung carcinoma

I Shanghai Junshi Biosciences

Click the tags to see associated articles and topics

View Article Details

Junshi Biosciences Announces Approval of Supplemental Application for Additional Indications of

Added to Collection on: 2022-11-22 06:47:42

Tags for this article:

Shanghai Junshi Biosciences

Ankylosing spondylitis

Shanghai

China

Click the tags to see associated articles and topics

View Article Details

China-Developed Covid Pill Matches Paxlovid, Study Shows - Caixin Global

Added to Collection on: 2022-12-30 09:29:37

Tags for this article:

Health

Articles

Pharmaceutical industry

Clinical research

Clinical pharmacology

Clinical trial

Design of experiments

Pfizer

Pfizer Inc.